(PL) Planet Labs PBC - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US72703X1063
Stock: Satellites, Imagery, Platform, APIs, Analytics
Total Rating 62
Risk 39
Buy Signal 0.67
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 87.5% |
| Relative Tail Risk | -12.0% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.65 |
| Alpha | 222.29 |
| Character TTM | |
|---|---|
| Beta | 1.997 |
| Beta Downside | 1.937 |
| Drawdowns 3y | |
|---|---|
| Max DD | 65.51% |
| CAGR/Max DD | 1.07 |
Description: PL Planet Labs PBC January 14, 2026
Planet Labs PBC designs, builds, and launches large constellations of small-satellite imagers to deliver high-cadence geospatial data via an online platform that supports planet monitoring, tasking, archival, APIs, basemaps, and analytics. Its product suite includes Tanager, a hyperspectral satellite covering visible to short-wave infrared wavelengths, and an Earth Observation platform that lets customers discover, extract, and act on proprietary data layers through custom solutions or GIS-compatible workflows.
The company serves a diversified client base spanning agriculture, mapping, energy, forestry, finance, insurance, and government agencies. As of the most recent public filings, Planet operates roughly 350 operational satellites, generates annual revenue in the low-hundreds of millions of dollars (≈ $210 M in FY 2023), and has reported year-over-year ARR growth of about 30 %, reflecting the broader market trend of rising demand for near-real-time Earth observation data for ESG reporting, precision farming, and climate risk assessment.
For a deeper quantitative comparison of Planet Labs’ valuation metrics, ValueRay offers a free, data-driven dashboard you may find useful.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -129.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 13.96 > 1.0 |
| NWC/Revenue: 200.2% < 20% (prev 71.39%; Δ 128.8% < -1%) |
| CFO/TA 0.10 > 3% & CFO 107.4m > Net Income -129.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 4.00 > 1.5 & < 3 |
| Outstanding Shares: last quarter (309.2m) vs 12m ago 5.42% < -2% |
| Gross Margin: 57.94% > 18% (prev 0.55%; Δ 5739 % > 0.5%) |
| Asset Turnover: 32.53% > 50% (prev 38.31%; Δ -5.78% > 0%) |
| Interest Coverage Ratio: -115.2 > 6 (EBITDA TTM -76.6m / Interest Expense TTM 1.02m) |
Altman Z'' -3.17
| A: 0.51 (Total Current Assets 754.1m - Total Current Liabilities 188.6m) / Total Assets 1.11b |
| B: -1.17 (Retained Earnings -1.30b / Total Assets 1.11b) |
| C: -0.14 (EBIT TTM -117.5m / Avg Total Assets 868.4m) |
| D: -1.71 (Book Value of Equity -1.29b / Total Liabilities 756.5m) |
| Altman-Z'' Score: -3.17 = D |
Beneish M -3.40
| DSRI: 1.02 (Receivables 46.3m/38.9m, Revenue 282.5m/241.7m) |
| GMI: 0.96 (GM 57.94% / 55.45%) |
| AQI: 0.57 (AQ_t 0.17 / AQ_t-1 0.30) |
| SGI: 1.17 (Revenue 282.5m / 241.7m) |
| TATA: -0.21 (NI -129.6m - CFO 107.4m) / TA 1.11b) |
| Beneish M-Score: -3.40 (Cap -4..+1) = AA |
What is the price of PL shares?
As of February 08, 2026, the stock is trading at USD 22.26 with a total of 9,418,520 shares traded.
Over the past week, the price has changed by -10.85%, over one month by +1.92%, over three months by +78.65% and over the past year by +260.19%.
Over the past week, the price has changed by -10.85%, over one month by +1.92%, over three months by +78.65% and over the past year by +260.19%.
Is PL a buy, sell or hold?
Planet Labs PBC has received a consensus analysts rating of 4.45.
Therefore, it is recommended to buy PL.
- StrongBuy: 7
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the PL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 24.4 | 9.5% |
| Analysts Target Price | 24.4 | 9.5% |
| ValueRay Target Price | 24.5 | 10.2% |
PL Fundamental Data Overview January 31, 2026
P/S = 31.2646
P/B = 26.7301
Revenue TTM = 282.5m USD
EBIT TTM = -117.5m USD
EBITDA TTM = -76.6m USD
Long Term Debt = 446.2m USD (from longTermDebt, last quarter)
Short Term Debt = 7.94m USD (from shortTermDebt, last quarter)
Debt = 461.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 18.0m USD (from netDebt column, last quarter)
Enterprise Value = 8.85b USD (8.83b + Debt 461.4m - CCE 443.3m)
Interest Coverage Ratio = -115.2 (Ebit TTM -117.5m / Interest Expense TTM 1.02m)
EV/FCF = 232.5x (Enterprise Value 8.85b / FCF TTM 38.1m)
FCF Yield = 0.43% (FCF TTM 38.1m / Enterprise Value 8.85b)
FCF Margin = 13.47% (FCF TTM 38.1m / Revenue TTM 282.5m)
Net Margin = -45.87% (Net Income TTM -129.6m / Revenue TTM 282.5m)
Gross Margin = 57.94% ((Revenue TTM 282.5m - Cost of Revenue TTM 118.8m) / Revenue TTM)
Gross Margin QoQ = 57.33% (prev 57.60%)
Tobins Q-Ratio = 8.00 (Enterprise Value 8.85b / Total Assets 1.11b)
Interest Expense / Debt = 0.22% (Interest Expense 1.02m / Debt 461.4m)
Taxrate = 21.0% (US default 21%)
NOPAT = -92.8m (EBIT -117.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.00 (Total Current Assets 754.1m / Total Current Liabilities 188.6m)
Debt / Equity = 1.32 (Debt 461.4m / totalStockholderEquity, last quarter 349.6m)
Debt / EBITDA = -0.24 (negative EBITDA) (Net Debt 18.0m / EBITDA -76.6m)
Debt / FCF = 0.47 (Net Debt 18.0m / FCF TTM 38.1m)
Total Stockholder Equity = 417.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -14.92% (Net Income -129.6m / Total Assets 1.11b)
RoE = -31.01% (Net Income TTM -129.6m / Total Stockholder Equity 417.8m)
RoCE = -13.60% (EBIT -117.5m / Capital Employed (Equity 417.8m + L.T.Debt 446.2m))
RoIC = -17.53% (negative operating profit) (NOPAT -92.8m / Invested Capital 529.4m)
WACC = 12.63% (E(8.83b)/V(9.29b) * Re(13.28%) + D(461.4m)/V(9.29b) * Rd(0.22%) * (1-Tc(0.21)))
Discount Rate = 13.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.31%
[DCF Debug] Terminal Value 60.09% ; FCFF base≈38.1m ; Y1≈33.3m ; Y5≈27.0m
Fair Price DCF = 0.78 (EV 262.6m - Net Debt 18.0m = Equity 244.6m / Shares 312.2m; r=12.63% [WACC]; 5y FCF grow -15.23% → 2.90% )
EPS Correlation: 56.98 | EPS CAGR: 68.61% | SUE: 0.78 | # QB: 0
Revenue Correlation: 94.89 | Revenue CAGR: 23.21% | SUE: 3.04 | # QB: 3
EPS next Quarter (2026-04-30): EPS=-0.02 | Chg30d=+0.002 | Revisions Net=-1 | Analysts=8
EPS next Year (2027-01-31): EPS=-0.07 | Chg30d=+0.008 | Revisions Net=-2 | Growth EPS=+41.6% | Growth Revenue=+27.1%
P/B = 26.7301
Revenue TTM = 282.5m USD
EBIT TTM = -117.5m USD
EBITDA TTM = -76.6m USD
Long Term Debt = 446.2m USD (from longTermDebt, last quarter)
Short Term Debt = 7.94m USD (from shortTermDebt, last quarter)
Debt = 461.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 18.0m USD (from netDebt column, last quarter)
Enterprise Value = 8.85b USD (8.83b + Debt 461.4m - CCE 443.3m)
Interest Coverage Ratio = -115.2 (Ebit TTM -117.5m / Interest Expense TTM 1.02m)
EV/FCF = 232.5x (Enterprise Value 8.85b / FCF TTM 38.1m)
FCF Yield = 0.43% (FCF TTM 38.1m / Enterprise Value 8.85b)
FCF Margin = 13.47% (FCF TTM 38.1m / Revenue TTM 282.5m)
Net Margin = -45.87% (Net Income TTM -129.6m / Revenue TTM 282.5m)
Gross Margin = 57.94% ((Revenue TTM 282.5m - Cost of Revenue TTM 118.8m) / Revenue TTM)
Gross Margin QoQ = 57.33% (prev 57.60%)
Tobins Q-Ratio = 8.00 (Enterprise Value 8.85b / Total Assets 1.11b)
Interest Expense / Debt = 0.22% (Interest Expense 1.02m / Debt 461.4m)
Taxrate = 21.0% (US default 21%)
NOPAT = -92.8m (EBIT -117.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.00 (Total Current Assets 754.1m / Total Current Liabilities 188.6m)
Debt / Equity = 1.32 (Debt 461.4m / totalStockholderEquity, last quarter 349.6m)
Debt / EBITDA = -0.24 (negative EBITDA) (Net Debt 18.0m / EBITDA -76.6m)
Debt / FCF = 0.47 (Net Debt 18.0m / FCF TTM 38.1m)
Total Stockholder Equity = 417.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -14.92% (Net Income -129.6m / Total Assets 1.11b)
RoE = -31.01% (Net Income TTM -129.6m / Total Stockholder Equity 417.8m)
RoCE = -13.60% (EBIT -117.5m / Capital Employed (Equity 417.8m + L.T.Debt 446.2m))
RoIC = -17.53% (negative operating profit) (NOPAT -92.8m / Invested Capital 529.4m)
WACC = 12.63% (E(8.83b)/V(9.29b) * Re(13.28%) + D(461.4m)/V(9.29b) * Rd(0.22%) * (1-Tc(0.21)))
Discount Rate = 13.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.31%
[DCF Debug] Terminal Value 60.09% ; FCFF base≈38.1m ; Y1≈33.3m ; Y5≈27.0m
Fair Price DCF = 0.78 (EV 262.6m - Net Debt 18.0m = Equity 244.6m / Shares 312.2m; r=12.63% [WACC]; 5y FCF grow -15.23% → 2.90% )
EPS Correlation: 56.98 | EPS CAGR: 68.61% | SUE: 0.78 | # QB: 0
Revenue Correlation: 94.89 | Revenue CAGR: 23.21% | SUE: 3.04 | # QB: 3
EPS next Quarter (2026-04-30): EPS=-0.02 | Chg30d=+0.002 | Revisions Net=-1 | Analysts=8
EPS next Year (2027-01-31): EPS=-0.07 | Chg30d=+0.008 | Revisions Net=-2 | Growth EPS=+41.6% | Growth Revenue=+27.1%